Increased detection of intracranial metastases with intravenous Gd-DTPA.
about
Time-delayed contrast-enhanced MRI improves detection of brain metastases: a prospective validation of diagnostic yield.Imaging of brain metastasesDevelopment of contrast media for magnetic resonance imaging.The optimal use of contrast agents at high field MRI.MR imaging of cerebral tumors: state of the art and work in progress.Improving lesion detection and visualization: implications for neurosurgical planning and follow-up.New directions in medical imaging of cancer. Magnetic resonance methods and single photon emission computed tomography.Nuclear magnetic resonance in clinical pharmacology and measurement of therapeutic response.Differential permeability and quantitative MR imaging of a human lung carcinoma brain xenograft in the nude rat.Contrast-enhanced synthetic MRI for the detection of brain metastases.Safety of gadoterate meglumine (Gd-DOTA) as a contrast agent for magnetic resonance imaging: results of a post-marketing surveillance study in JapanCorrelation between choline level and Gd-DTPA enhancement in patients with brain metastases of mammary carcinoma.Targeting potassium channels for increasing delivery of imaging agents and therapeutics to brain tumors.Pitfalls of contrast-enhanced imaging in the nervous system.Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography.Effect of imaging time in the magnetic resonance detection of intracerebral metastases using single dose gadobutrolComputed tomography versus magnetic resonance imaging. Of the pediatric central nervous system. Techniques, indications, and examples.Value of contrast enhanced CT scanning in the non-trauma emergency room patient.Gadobenate dimeglumine-enhanced magnetic resonance imaging of intracranial metastases: effect of dose on lesion detection and delineation.Gadolinium-enhanced magnetization transfer contrast imaging of intracranial tumors.Phase III clinical evaluation of Gd-HP-DO3A in head and spine disease.Contrast-enhanced FLAIR imaging in combination with pre- and postcontrast magnetization transfer T1-weighted imaging: usefulness in the evaluation of brain metastases.Renal metastasis from choriocarcinoma: MRI appearance.In vivo relaxometry of three brain tumors in the rat: effect of Mn-TPPS, a tumor-selective contrast agent.Quantification of dispersion of Gd-DTPA from the initial area of enhancement into the peritumoral zone of edema in brain tumors.Additional MR contrast dosage for radiologists' diagnostic performance in detecting brain metastases: a systematic observer study at 3 T.Comparison of spin echo T1-weighted and FLASH 90 degrees gadolinium-enhanced magnetic resonance imaging in the detection of cerebral metastases.Magnetic resonance imaging assessment of fibrovascular ingrowth into porous polyethylene orbital implants.Application of Synthetic MRI for Direct Measurement of Magnetic Resonance Relaxation Time and Tumor Volume at Multiple Time Points after Contrast Administration: Preliminary Results in Patients with Brain Metastasis.
P2860
Q30276051-AC9A99BE-AEB6-481B-A495-B53BD3346786Q30635460-AB522A74-0CEC-44C2-95DF-EB5531322C5DQ30986306-F9EB2E0F-E796-4107-93C7-A2708FE6E1D6Q31033254-91EB2D64-733B-4370-A1D1-A08893CE2B12Q31036034-F25E2C10-E715-4166-9A3C-AA16C7C9152DQ33292588-2994D7BA-D81C-4B8B-8922-B44572CD22E1Q33515934-59D025CA-5ABF-4930-B92C-95A45C4698FDQ34398182-0B8E5FE5-BDAB-4A21-A802-8F7E4E489977Q35796256-17F63D7E-2B0E-4ABB-BC49-7056190C74F7Q36613978-FCDFA361-2C41-4DA7-BF08-DC40F0F8EB75Q36649891-BBA3F5A4-07E2-420C-9C0C-E9A37A5DC6B8Q36710813-EE820B1D-4590-4B96-BC8B-99CE92F167DAQ36881899-712FBD86-736F-4664-BA5A-454F2A4AA5FDQ37041557-28BF756E-67CC-44DA-8651-EDCDFBABD7E8Q37224527-4346C332-756E-4614-A30D-EBF2AE521BD4Q37541200-3F8D9E0C-6F81-441A-BDD3-3A94E3AB1FADQ38145418-09AFC7A2-2006-4E44-9231-5E8BC0821A8EQ42076191-D7F8C83F-E5D5-45BC-B4C6-7FE8136B3BF5Q43825978-0B690342-08B5-44D3-B771-19DD73683570Q45085942-98DB289E-FC39-43B3-81F7-4E05BF8F8D26Q46585054-F7CE5B90-DBF3-480F-9A6F-D103E117DB0CQ48259844-A7A0F1E5-B186-4564-AF4C-53627C7D54E1Q48335464-D5FA922B-2E22-4E48-8E14-83D3B7753824Q48361329-4EAF6665-8713-4450-AD17-919328AB469AQ48683635-5CB2599C-8591-4DC3-891D-58A176A7E4B6Q48701281-714B0AAC-B0F7-4CA9-9198-619481FB5657Q48899826-4D39FC61-A363-471B-ADE9-2160E4F42752Q51183817-B531A51D-29C4-48E8-847B-B7FE277DF623Q55361064-30F2DEA2-D300-48BA-8BAA-ED0D71A5E8F0
P2860
Increased detection of intracranial metastases with intravenous Gd-DTPA.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh-hant
name
Increased detection of intracranial metastases with intravenous Gd-DTPA.
@en
Increased detection of intracranial metastases with intravenous Gd-DTPA.
@nl
type
label
Increased detection of intracranial metastases with intravenous Gd-DTPA.
@en
Increased detection of intracranial metastases with intravenous Gd-DTPA.
@nl
prefLabel
Increased detection of intracranial metastases with intravenous Gd-DTPA.
@en
Increased detection of intracranial metastases with intravenous Gd-DTPA.
@nl
P2093
P1433
P1476
Increased detection of intracranial metastases with intravenous Gd-DTPA.
@en
P2093
Hesselink JR
Middleton MS
P304
P356
10.1148/RADIOLOGY.165.3.3317496
P407
P577
1987-12-01T00:00:00Z